Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Evidence That Cannabis Exposure, Abuse, and Dependence Are Related to Glutamate Metabolism and Glial Function in the Anterior Cingulate Cortex

A 1H-Magnetic Resonance Spectroscopy Study

Bibliographic Data

ID15523657
AuthorsJeremy J Watts (0000-0003-1751-5409, Centre for Addiction and Mental Health), Ranjini Garani Ramesh (0000-0001-7090-672X, University of Toronto), Ranjini Garani, Tania da Silva (0000-0003-1887-2598, Centre for Addiction and Mental Health), Nittha Lalang (Centre for Addiction and Mental Health), Sofia Chavez (0000-0002-6532-911X, Centre for Addiction and Mental Health), R Mizrahi (0000-0001-6667-7928, Centre for Addiction and Mental Health, corresponding author)
Year2020
Volume11
Pages764-764
Publication date2020-08-20
Open AccessYes
TypeARTICLE
VenueFrontiers in Psychiatry (JOURNAL)
Journal identifiersISSN: 1664-0640 • E-ISSN: 1664-0640
PublisherFrontiers Media (PUBLISHER • CH)
DOI10.3389/fpsyt.2020.00764
PMID32973572
OpenAlexW3081479150
LanguageEN
References cited50

There is evidence that long-term cannabis use is associated with alterations to glutamate neurotransmission and glial function. In this study, 26 long-term cannabis users (males=65.4%) and 47 non-cannabis using healthy controls (males=44.6%) underwent proton magnetic resonance spectroscopy ( 1 H-MRS) of the anterior cingulate cortex (ACC) in order to characterize neurometabolite alterations in cannabis users and to examine associations between neurometabolites, cannabis exposure, and cannabis use behaviors. Myo-inositol, a marker of glial function, and glutamate metabolites did not differ between healthy controls and cannabis users or cannabis users who met criteria for DSM5 cannabis use disorder (n=17). Lower myo-inositol, a putative marker of glial function, was related to greater problematic drug use (F 1,22 = 11.95, p=.002; Cohen's f=0.59, large effect; Drug Abuse Screening Test) and severity of cannabis dependence (F 1,22 = 6.61, p=.17; Cohen's f=0.44, large effect). Further, past-year cannabis exposure exerted different effects on glutamate and glutamate+glutamine in males and females (glutamate: F 1,21 = 6.31, p=.02; glutamate+glutamine: F 1,21 = 7.20, p=.014), such that greater past-year cannabis exposure was related to higher concentrations of glutamate metabolites in male cannabis users (glutamate: F 1,14 = 25.94, p=.00016; Cohen's f=1.32, large effect; glutamate+glutamine: F 1,14 = 23.24, p=.00027, Cohen's f=1.24, large effect) but not in female cannabis users (glutamate: F 1,6 = 1.37, p=0.78; glutamate+glutamine: F 1,6 = 0.001, p=.97). The present results extend existing evidence of altered glial function and glutamate metabolism with cannabis use by providing evidence linking problematic drug use behaviors with glial function as measured with myo-inositol and recent chronic cannabis exposure to alterations in glutamate metabolism. This provides novel directions for the interrogation of the impact of cannabis use on brain neurochemistry

Amino acid · Anterior cingulate cortex · Biology · Cannabis · Cognition · Glutamate receptor · Glutamine · Psychiatry · Receptor · Cannabis and Cannabinoid Research · Epilepsy research and treatment · Medicine · Neuroscience · Neuroscience and Neuropharmacology Research · Psychology · Biochemistry · Endocrinology · Internal Medicine

  • Association Between Recreational Marijuana Legalization in the United States and Changes in Marijuana Use and Cannabis Use Disorder From 2008 to 2016

    Magdalena Cerdá, Christine Mauro et al.•JAMA Psychiatry•2020

Highly citedNo

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae